We are live on ! Find out more
DCM

Dupont Capital Management Portfolio holdings

AUM $2.18M
1-Year Est. Return 50.81%
This Fund
S&P 500
This Quarter Est. Return
+21.35%
1 Year Est. Return
+50.81%
3 Year Est. Return
+136.7%
5 Year Est. Return
+194.47%
10 Year Est. Return
+665.34%
AUM
$4.56B
AUM Growth
+$362M
Cap. Flow
-$406M
Cap. Flow %
-8.91%
Top 10 Hldgs %
34.08%
Holding
1,479
New
212
Increased
384
Reduced
703
Closed
131

Sector Composition

Rank Sector Weight
1 Technology 14.92%
2 Financials 11%
3 Healthcare 9.49%
4 Consumer Discretionary 9.18%
5 Industrials 8.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IMAX icon
1026
IMAX
IMAX
$2.81B
$257K 0.01%
22,910
-2,046
-8% -$23.9K
WH icon
1027
Wyndham Hotels & Resorts
WH
$5.49B
$256K 0.01%
6,014
-2,840
-32% -$116K
VRTU
1028
DELISTED
Virtusa Corporation
VRTU
$256K 0.01%
7,888
-705
-8% -$21.8K
HE icon
1029
Hawaiian Electric Industries
HE
$2.06B
$255K 0.01%
7,068
-837
-11% -$32.4K
EIGI
1030
DELISTED
Endurance International Group Holdings, Inc.
EIGI
$255K 0.01%
+63,302
New +$187K
AGCO icon
1031
AGCO
AGCO
$7.11B
$254K 0.01%
4,587
-1,644
-26% -$85.7K
MRO
1032
DELISTED
Marathon Oil Corporation
MRO
$254K 0.01%
41,431
-43,757
-51% -$242K
FUSE.U
1033
DELISTED
Fusion Acquisition Corp. Units, each consisting of one share of Class A common stock, $0.0001 par va
FUSE.U
$254K 0.01%
+25,000
New +$254K
VG
1034
DELISTED
Vonage Holdings Corporation
VG
$253K 0.01%
+25,143
New +$226K
MNTV
1035
DELISTED
Momentive Global Inc. Common Stock
MNTV
$252K 0.01%
+10,692
New +$195K
IART icon
1036
Integra LifeSciences
IART
$1.35B
$251K 0.01%
5,339
-632
-11% -$31.1K
SRGA
1037
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
$251K 0.01%
+2,629
New +$196K
TLMD
1038
DELISTED
SOC Telemed, Inc. Class A Common Stock
TLMD
$251K 0.01%
25,000
EME icon
1039
Emcor
EME
$36.8B
$250K 0.01%
3,780
-4,299
-53% -$269K
MAXR
1040
DELISTED
Maxar Technologies Inc. Common Stock
MAXR
$250K 0.01%
+13,944
New +$180K
NDAQ icon
1041
Nasdaq
NDAQ
$53.5B
$249K 0.01%
6,255
-117
-2% -$4.36K
UNIT
1042
Uniti Group
UNIT
$2.31B
$249K 0.01%
+26,604
New +$200K
XYL icon
1043
Xylem
XYL
$28.5B
$249K 0.01%
+3,830
New +$253K
NEO icon
1044
NeoGenomics
NEO
$2.11B
$248K 0.01%
+7,995
New +$222K
RYZ
1045
Ryerson Holding Corp
RYZ
$1.5B
$248K 0.01%
44,114
-3,939
-8% -$19.5K
SCL icon
1046
Stepan Co
SCL
$1.48B
$247K 0.01%
+2,539
New +$239K
SRDX
1047
DELISTED
Surmodics
SRDX
$247K 0.01%
+5,701
New +$216K
GNMK
1048
DELISTED
GenMark Diagnostics, Inc
GNMK
$247K 0.01%
16,802
-27,824
-62% -$283K
SAFE
1049
DELISTED
Safehold Inc.
SAFE
$247K 0.01%
+4,295
New +$235K
NI icon
1050
NiSource
NI
$20.1B
$246K 0.01%
+10,802
New +$261K

Similar funds

Dupont Capital Management's Q2 2020 Portfolio in Review

As of Q2 2020, Dupont Capital Management held 1,479 positions worth $4.56B, up 8.6% from $4.2B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Dupont Capital Management withdrew a net $406M in Q2 2020, closing 131 positions and reducing 703 holdings. Its most notable exit was Allergan plc, an estimated $16.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 13% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Dupont Capital Management opened a new position in State Street SPDR Portfolio S&P 500 Value ETF worth $45.2M.

  • Dupont Capital Management's largest Q2 2020 buy was State Street SPDR Portfolio S&P 500 Value ETF: 1,559,776 shares worth $45.2M.
  • Dupont Capital Management added most to Target in Q2 2020, an estimated $7.78M increase.
  • Dupont Capital Management's biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $435M.
  • Dupont Capital Management fully exited Allergan plc in Q2 2020, selling an estimated $16.8M.
  • Dupont Capital Management's ten largest holdings make up 34% of its $4.56B portfolio in Q2 2020.
  • Dupont Capital Management opened 212 new positions and closed 131 in Q2 2020.
  • Dupont Capital Management's portfolio value rose 8.6% quarter-over-quarter to $4.56B.

Based on Dupont Capital Management's 13F filing for Q2 2020, filed 24 Jul 2020.